Crotonaldehyde-Deoxyguanosine Adducts
Chem. Res. Toxicol., Vol. 14, No. 11, 2001 1507
Hz, J 2 ) 4.8 Hz), 1.34 (d, 3H, CH3, J ) 6.8 Hz). HRMS (FAB+):
calcd for [M + H]+ C12H16NO3, 222.1130; found, 222.1122.
odology to the preparation of oligodeoxynucleotides con-
taining site-specific crotonaldehyde adducts.
(S)-3-(Ben zoyla m in o)bu tyr a ld eh yd e (5S). Methyl (S)-3-
(benzoylamino)butanoate (0.47 g, 2.12 mmol) was dissolved in
20 mL of anhydrous methylene chloride. The solution was cooled
to -78 °C. Diisobutylaluminum hydride (DIBAL-H) (2.12 mL
of 1 M solution in hexane, 2.12 mmol) was added over 15 min;
the mixture was stirred at -78 °C for 1 h. Additional DIBAL-H
(2.12 mL, 2.12 mmol) was added over 15 min and the mixture
was stirred for 1 h at -78 °C, followed by quenching at -78 °C
with 4 mL of a saturated aqueous solution of NH4Cl. Hydro-
chloric acid (4%, 4 mL) was added and the mixture was warmed
to room temperature. After 0.5 h, the mixture was extracted
several times with CH2Cl2 and the combined organic layers were
dried over MgSO4. The organic solvents were removed and the
residue was purified by chromatography on a silica gel column
(hexane/EtOAc, 1:1) to give 0.25 g (63%) of the substituted
butyraldehyde (5S) (25). 1H NMR (CDCl3) δ 9.85 (bs, 1H, CHO),
7.75 (m, 2H, o-Ph), 7.46 (m, 3H, m- and p-Ph), 6.49 (s, 1H, NH),
4.64 (m, 1H, CH), 2.81 (m, 2H, CH2), 1.40 (d, 3H, CH3, J ) 6.9
Hz). HRMS (FAB+): calcd for C11H14NO2 [M + H]+, 192.1025;
found, 192.1019.
Exp er im en ta l P r oced u r es
Gen er a l Meth od s. Thin-layer chromatography was per-
formed on silica gel glass plates (Merck, Silica Gel 60 F254, layer
thickness 0.25 mm). The chromatograms were visualized under
UV light (254 nm) or by staining with an anisaldehyde/sulfuric
acid solution, followed by heating. Column chromatography was
performed using silica gel (Merck, 70-230 mesh). HPLC analy-
ses and purifications were carried out on a gradient HPLC
(Beckman Instruments; System Gold software) equipped with
pump module 125 and photodiode array detector module 168.
For monitoring reactions and purification a YMC ODS-AQ
column (250 × 4.6 mm, flow rate 1.5 mL/min, or 250 × 10 mm,
flow rate, 5 mL/min) monitored at 260 nm was used with H2O-
acetonitrile for nucleosides, and 0.1 M ammonium formate-
acetonitrile for oligonucleotides. Gradient A: 99% H2O for
initial, 15 min linear gradient to 90% H2O, 5 min linear gradient
to 80% H2O, 3 min linear gradient to 20% H2O, 2 min isocratic
at 20% H2O, 3 min gradient to 99% H2O. Gradient B: 99% H2O
for initial, 5 min linear gradient to 94% H2O, 15 min linear
gradient to 91% H2O, 3 min linear gradient to 20% H2O, 2 min
isocratic at 20% H2O, 3 min gradient to 99% H2O.
In str u m en ta tion . 1H NMR spectra were recorded at 400.13
MHz on a Bruker AM400 NMR spectrometer in D2O or DMSO-
d6. Low and high-resolution FAB mass spectra were obtained
at the Mass Spectrometry Facility at the University of Notre
Dame, Notre Dame, Indiana. Negative ion MALDI-TOF1 mass
spectra of modified oligonucleotides were obtained on a Voyager
Elite DE instrument (Perseptives Biosystems) using a 3-hy-
droxypicolinic acid (3-HPA) matrix containing ammonium hy-
drogen citrate (7 mg/mL) to suppress multiple sodium and
potassium adducts. CD spectra were recorded in water at 25
°C on a J ASCO J -700 spectropolarimeter.
(S)-2-(Ben zoyla m in o)-4-p en ten e (6S). A solution of meth-
ylidenetriphenyl-phosphorane (prepared from methyltriphen-
ylphosphonium bromide (0.56 g, 1.57 mmol) and n-BuLi (0.560
mL of a 2.5 M solution in hexane, 1.4 mmol) in THF (20 mL)
was added to a stirred solution of the above aldehyde (0.25 g,
1.13 mmol) in dry THF (5 mL) at -78 °C. The reaction was
monitored by TLC by adding small aliquots to a mixture of
saturated aqueous (NH4)2SO4 and EtOAc. After the starting
material had been consumed, the mixture was warmed to room
temperature and poured into saturated aqueous (NH4)2SO4,
which was extracted with ether. The extract was dried over
MgSO4, and after evaporation of the solvents, the residue was
purified by chromatography on a silica gel column (hexane/
EtOAc, 2:1) to give 103 mg (42%) of (S)-2-(benzoylamino)-4-
pentene (6S). 1H NMR (CDCl3) δ 7.74 (m, 2H, o-Ph), 7.44 (m,
3H, m- and p-Ph), 5.95 (bs, 1H, NH), 5.84 (m, 1H, ) CH), 5.14
(m, 2H, ) CH2), 4.30 (m, 1H, CH), 2.35 (m, 2H, CH2), 1.26 (d,
3H, CH3, J ) 6.6 Hz). HRMS (FAB+): calcd for C12H16NO [M
+ H]+, 190.1232; found, 190.1227.
4(S)-Am in o-1,2-(R a n d S)-p en ta n ed iol (7S). (S)-2-(Ben-
zoylamino)-4-pentene (6S, 100 mg, 0.53 mmol) was added to a
mixture of water (5 mL), acetone (2 mL), N-methylmorpholine
N-oxide (71 mg, 0.6 mmol) and OsO4 (1-2 mg). The mixture
was stirred overnight at room temperature and the solvents
were evaporated. The residue was purified on a silica gel column
(ether/methanol, 95:5) to give 93 mg (79%) of 4(S)-(benzoyl-
amino)-1,2(R and S)-pentanediol (7S). 1H NMR (DMSO-d6) δ
8.20 (m, 1H, NH), 7.82 (m, 2H, o-Ph), 7.47 (m, 3H, m- and p-Ph),
4.49 (m, 2H, 2× OH), 4.21 (m, 1H, CHN), 3.50 (m, 1H, CHO),
3.29 (m, 2H, CH2O), 1.35-1.73 (m, 2H, CH2C), 1.16 (m, 3H,
CH3). HRMS (FAB+) [M + H]+: calcd, 224.1287; found,
224.1286.
(S)-3-(Ben zoyla m in o)bu ta n oic Acid (24). Benzoyl chloride
(0.50 g, 0.42 mL, 3.58 mmol) was added to a stirred solution of
(S)-3-aminobutanoic acid (4S, 0.50 g, 3.58 mmol, Fluka) in 10
mL of 1 M NaOH. The mixture was cooled (ice bath) during the
addition and stirred at room temperature for 24 h. TLC (ether,
visualized with ninhydrin spray) showed complete consumption
of the starting amino acid. The mixture was acidified (pH ∼6),
extracted with ether and dried over MgSO4. The ether was
evaporated and the residue was purified by a silica gel column
1
(ether) to give 0.48 g (65%) of the product as a white solid. H
NMR (DMSO-d6) δ 12.16 (bs, 1H, COOH), 8.28 (m, 1H, NH),
7.80 (m, 2H, o-Ph), 7.46 (m, 3H, m- and p-Ph), 4.34 (m, 1H, CH),
2.56 (dd, 1H, CH2, J 1 ) 15.3 Hz, J 2 ) 6.8 Hz), 2.38 (dd, 1H, J 1
) 15.3 Hz, J 2 ) 4.3 Hz), 1.17 (d, 3H, CH3, J ) 6.6 Hz). HRMS
(FAB+): calcd for C11H14NO3 [M + H]+, 208.0974; found,
208.0981.
Meth yl Ester of (S)-3-(Ben zoyla m in o)bu ta n oic Acid . (S)-
3-(Benzoylamino)butanoic acid (0.48 g, 2.32 mmol) was dissolved
in 50 mL of methanol containing 4-5 drops of concentrated H2-
SO4. The mixture was refluxed for 1 h. Most of the methanol
was evaporated, water was added and the mixture was extracted
three times with ether. The combined ether layers were washed
with satd. NaHCO3 solution and water and dried over MgSO4.
Evaporation of the solvent gave 0.47 g (92%) of the ester, which
was used in the next step without purification. 1H NMR (CDCl3)
δ 7.78 (m, 2H, o-Ph), 7.46 (m, 3H, m- and p-Ph), 6.95 (bs, 1H,
NH), 4.56 (m, 1H, CH), 3.72 (s, 3H, COOCH3), 2.69 (dd, 1H,
CH2, J 1 ) 15.9 Hz, J 2 ) 5.3 Hz), 2.62 (dd, 1H, CH2, J 1 ) 15.9
The diol (90 mg, 0.4 mmol) in 6 M HCl (10 mL) was refluxed
for 4 h. The solution was evaporated to dryness, water was
added and the mixture was neutralized (pH 6.0). The water were
evaporated again and the 4(S)-amino-1,2(R and S)-pentanediol
was purified on an ion exchange column (DOWEX 50-X8). The
aminodiol was eluted with 1 M NH4OH to give, after evaporation
1
to dryness, 40 mg (83%) of amino alcohol 7S. H NMR (DMSO-
d6) δ 3.75 (m, 1H, CHOH), 3.50 (m, 1H, 1× CH2OH), 3.41 (m,
1H, CH2OH), 3.12 (m, 1H, CHNH), 1.46 (m, 2H, CH2), 1.08 (m,
3H, CH3). HRMS (FAB+) [M + H]+: calcd, 120.1025; found,
120.1002.
N2-(1(S)-m eth yl-3(R a n d S),4-d ih yd r oxybu tyl)d eoxygu a -
n osin e (9S). Amino alcohol 7S (9.8 mg, 0.082 mmol) was added
to a mixture of O6-trimethylsilylethyl-2-fluoro-deoxyinosine (8,
20 mg, 0.054 mmol), DMSO (150 µL), and diisopropylethylamine
(50 µL). The mixture was stirred at 55 °C for 7 h. The reaction
was stopped and the solvents were evaporated under vacuum.
The residue was dissolved in 5% acetic acid (1 mL) and stirred
1
Abbreviations: DIBAL-H, diisobutylaluminum hydride; FAB MS,
fast-atom bombardment mass spectrometry; MALDI TOF MS, matrix-
assisted laser desorption/ionization time-of-flight mass spectrometry;
HRMS, high-resolution mass spectrometry; TMSE, trimethylsilylethyl.
COSY, correlation spectroscopy; HMBC, heteronuclear multibond
correlation spectroscopy (long-range 13C-1H scalar correlated 2D NMR
experiment).